Management of worsening multiple sclerosis with mitoxantrone: a review.

@article{Fox2006ManagementOW,
  title={Management of worsening multiple sclerosis with mitoxantrone: a review.},
  author={Edward J. Fox},
  journal={Clinical therapeutics},
  year={2006},
  volume={28 4},
  pages={461-74}
}
BACKGROUND Mitoxantrone, an intravenously administered immunosuppressant that inhibits T-cell, B-cell, and macrophage proliferation, is indicated for reducing neurologic disability and relapse frequency in patients with secondary progressive multiple sclerosis (SPMS), progressive relapsing MS, or worsening relapsing-remitting MS (RRMS). OBJECTIVE This article reviews the pathogenesis and natural history of MS and examines the available treatment options for patients with RRMS, worsening RRMS… CONTINUE READING
35 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Similar Papers

Loading similar papers…